Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.69 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 4/20 | 0.69 |
| ▸ | HPGD | P15428 | 3/20 | 0.69 |
| ▸ | RECQL | P46063 | 3/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.69 |
| ▸ | APEX1 | P27695 | 2/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.66 |
| ▸ | ELANE | P08246 | 4/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | TTR | P02766 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16226983 | 0.87 | ELANE (0.83) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| Lunatin SCHEMBL16226694 | 0.82 | ELANE (0.76) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| Emodic Acid SCHEMBL5073407 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| Emodic Acid SCHEMBL29360148 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| Lunatin SCHEMBL30761640 | 0.82 | ELANE (0.76) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| SCHEMBL16226554 | 0.82 | ELANE (0.62) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| SCHEMBL14345807 | 0.82 | ALDH1A1 (0.73) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| SCHEMBL16225641 | 0.81 | ALDH1A1 (0.73) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| SCHEMBL28243779 | 0.80 | MAPT (0.63) | ALDH1A1MAPTCYP3A4POLBHPGD | |
| SCHEMBL18601968 | 0.80 | ALDH1A1 (0.71) | ALDH1A1MAPTCYP3A4POLBHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368695-A1 | Atranorin biosynthesis gene derived from lichens and uses thereof | INDUSTRY ACADEMIC COOPERATION FOUNDATION OF SUNCHON NATIONAL UNIV (KR) | 2025-12-04 | — | — | US | disclosed |
| US-20230002258-A1 | SYSTEMS AND METHODS FOR OXIDIZING DISINFECTANTS COMBINED WITH MOVING BED BIOFILM REACTORS | Headworks Bio, Inc. | 2023-01-05 | — | — | US | disclosed |
| WO-2022260402-A1 | ATRANORIN BIOSYNTHESIS GENE DERIVED FROM LICHEN AND USE THEREOF | 순천대학교 산학협력단 | 2022-12-15 | — | — | WO | disclosed |
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | THE GENERAL HOSPITAL CORPORATION (US) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | IL2RA, CD74, IL2 | ALDH1A1 1004/4885MAPT 3619/4885CYP3A4 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.